SRDX News and Press, Surmodics Inc. From 04/01/21

Sublime™ Radial Access .014 RX PTA Dilatation Catheter, Sublime Radial Access Guide Sheath Deliver Outstanding Performance in Initial Physician Evaluations Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the ...

Wall Street usually prices in events before they happen, and that is as true for Surmodics (NASDAQ: SRDX) as it is for any other company.  If news is anticipated, and investors want to know what to expect, a simple review of the stock's price action is one of the best ways to do th...

Presentation Times and Weblinks Released for Over 125 Presenting Companies Wednesday and Thursday, March 24-25, 2021 NEW YORK, NY / ACCESSWIRE / March 23, 2021 / Sidoti & Company, LLC proudly releases the presentation schedule, with weblink click-throughs, for its Spring 2021 Vir...

Investors often shrug off the impact of stimulus, but when fabricated demand comes into the stock market everything is affected, even Surmodics (NASDAQ: SRDX) and other stocks that might not be direct beneficiaries.  They say, a rising tide lifts all boats, and multiple expansion i...

Webcast is Live on Thursday, March 25, at 10:00 a.m. (ET) Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that Gary Maharaj, president and chief executive officer, and T...

A tell is a precursor of a stock's next move, and investors in Surmodics (NASDAQ: SRDX) look for these indicators all the time.  the good news is, tells are there for investors to see every day. For example, we have provided this data for SRDX in the trading plans and summary ...

Traditionally Wall Street has used fundamental analysis to make investment decisions in stocks like Surmodics (NASDAQ: SRDX) but sometimes the most revealing aspect of the fundamental health of a company can be found through an observation of its price action.  Price action was use...

Image source: The Motley Fool. Surmodics Inc (NASDAQ: SRDX) Q1 2021 Earnings Call Feb 9, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: Surmodics Inc (SRDX) Q1 2021 Earnings Call Transcript

Surmodics, Inc. (SRDX) Q1 2021 Earnings Conference Call February 9, 2021 8:30 A.M. ET Company Participants Tim Arens - Senior Vice President of Finance and Chief Financial Officer Gary Maharaj - President and Chief Executive Officer Conference Call Participants Mike Matson - Needham & Com...

Surmodics (SRDX): Q4 Non-GAAP EPS of $0.02 beats by $0.11; GAAP EPS of -$0.02 beats by $0.12.Revenue of $22.3M (-1.3% Y/Y) misses by $0.07M.Shares +2.2% PM.Press Release For further details see: Surmodics EPS beats by $0.11, misses on revenue